13 Chen Chen X X Hong Hong X X Chen Chen G G Xue Xue J J Huang Huang J J Wang Wang F F et al et al The Pan-Immune-Inflammation Value Predicts the Survival of Patients with Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer Treated with First-line ALK Inhibitor The Pan-Immune-Inflammation Value Predicts the Survival of Patients with Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer Treated with First-line ALK Inhibitor Transl Oncol Transl Oncol 2022 2022 17 17 101338 101338. The gene discussed is ALK; the disease is non-small cell lung carcinoma.